guidelines:
  1: SLEDAI-2K.v1
test_cases:
- id: Default
  input:
    1: {}
  expected_output:
    1: {}
- id: Calculate SLEDAI-2K
  input:
    1:
      gt0042|Recent onset seizure: 0|local::at0005|No|
      gt0043|Psychosis: 0|local::at0005|No|
      gt0044|Organic brain syndrome: 0|local::at0005|No|
      gt0045|Visual disturbance: 8|local::at0006|Yes|
      gt0046|New onset sensory or motor neuropathy involving cranial nerves: 0|local::at0005|No|
      gt0047|Lupus headache: 8|local::at0006|Yes|
      gt0048|New onset stroke: 8|local::at0006|Yes|
      gt0049|Vasculitis: 0|local::at0005|No|
      gt0050|Arthritis: 0|local::at0005|No|
      gt0051|Myositis: 0|local::at0005|No|
      gt0052|Heme-granular or RBC urinary casts: 4|local::at0006|Yes|
      gt0053|Hematuria: 0|local::at0005|No|
      gt0054|Proteinuria: 4|local::at0006|Yes|
      gt0055|Pyuria: 2|local::at0006|Yes|
      gt0056|Inflammatory-type rash: 0|local::at0005|No|
      gt0057|Alopecia: 2|local::at0006|Yes|
      gt0058|Oral or nasal mucosal ulcers: 0|local::at0005|No|
      gt0059|Pleuritic chest pain with pleural rub/effusion or pleural thickening: 0|local::at0005|No|
      gt0060|Pericarditis: 2|local::at0006|Yes|
      gt0061|Low complement: 0|local::at0005|No|
      gt0062|High DNA binding: 2|local::at0006|Yes|
      gt0063|Temp >100.4 °F (38°C): 0|local::at0005|No|
      gt0064|Platelets <100 x 109/L: 0|local::at0005|No|
      gt0065|WBC <3 x 109/L: 1|local::at0006|Yes|
  expected_output:
    1:
      gt0066|SLEDAI-2K: 41
      gt0067|Interpretation: Authors recommend a cutoff of 3 or 4 to define active disease and the need to increase therapy.
